Results 91 to 100 of about 9,749 (194)

Mesenchymal stromal cells plus basiliximab improve the response of steroid-refractory acute graft-versus-host disease as a second-line therapy: a multicentre, randomized, controlled trial

BMC Medicine
Background For patients with steroid-refractory acute graft-versus-host disease (SR-aGVHD), effective second-line regimens are urgently needed. Mesenchymal stromal cells (MSCs) have been used as salvage regimens for SR-aGVHD in the past.
Haixia Fu, Xueyan Sun, Ren Lin, Yu Wang, Li Xuan, Han Yao, Yuanyuan Zhang, Xiaodong Mo, Meng lv, Fengmei Zheng, Jun Kong, Fengrong Wang, Chenhua Yan, Tingting Han, Huan Chen, Yao Chen, Feifei Tang, Yuqian Sun, Yuhong Chen, Lanping Xu, Kaiyan Liu, Xi Zhang, Qifa Liu, Xiaojun Huang, Xiaohui Zhang   +24 more
doaj   +1 more source

Impact of kidney and liver transplant immunosuppression regimens on sinonasal disease

American Journal of Otolaryngology
Objective: To compare differences in the rate of chronic rhinosinusitis with or without nasal polyposis (CRSwNP, CRSsNP), allergic rhinitis (AR), and acute invasive fungal sinusitis (IFS) among kidney and liver transplant patients following different ...
Robert E. Africa, Anusha Dabak, Annika Nambiar, Brian J. McKinnon, Scott A. Hardison   +4 more
doaj   +1 more source

Basiliximab induction in renal transplantation: Long-term outcome

, 2013
Anti-IL-2 receptor has been proven to be effective in reducing the rate of acute rejection in kidney transplantation and also in improving the graft and patient survival rates. In this study, we retrospectively reviewed the role of the anti-IL-2 receptor,
Amit Gupta, Raj K Sharma, Mahendra Atlani   +2 more
core   +1 more source

Comparative efficacy and safety of induction therapy in solid organ transplantation: a systematic review and network meta-analysis

Frontiers in Immunology
ObjectiveTo comparatively evaluate the efficacy and safety of induction therapies in solid organ transplantation (SOT) using a Bayesian network meta-analysis (NMA).MethodsRandomized controlled trials (RCTs) assessing induction therapies were ...
Junjie Sun, Chao Hu, Qingwen Liang, Yanqing Yu, Ning Wen, Jianhui Dong, Haibin Li, Xuyong Sun   +7 more
doaj   +1 more source

Efficacy and safety of basiliximab with a tacrolimus-based regimen in liver transplant recipients

, 2004
Background. Induction with monoclonal antibodies for prevention of acute cellular rejection (ACR) may avoid many of the adverse events associated with polyclonal antibodies.
Gruttadauria, Salvatore, Marino, Ignazio R., Scott, Victor L., Cintorino, Davide, Foglieni, Carlo Scotti, Piazza, Tommaso, Doria, Cataldo, Lauro, Augusto   +7 more
core   +1 more source

Locus-specific HLA matching and induction therapy in simultaneous pancreas-kidney transplantation: a national UK cohort study. [PDF]

Transpl Int
Malik AK, Banks J, Counter C, Simmonds L, Tingle SJ, Sinha S, Muthasamy A, Sutherland A, Casey J, Drage M, van Dellen D, Callaghan CJ, Elker D, Manas DM, Pettigrew GJ, Russell N, Sheerin NS, Wilson CH, White SA.   +18 more
europepmc   +1 more source

The Use of Long‐Term Monthly Basiliximab Infusions as Rescue Maintenance Immunosuppression in Pancreas Transplant Recipients

This single-center retrospective study was designed to evaluate the use of basiliximab as an alternative rescue maintenance immunosuppression in situations where standard maintenance immunosuppression is not tolerated after a pancreas transplant.
Powelson, John A., Lutz, Andrew J., Chen, Jeanne M., Fridell, Jonathan A., Mangus, Richard S., Yaqub, Muhammad S., Sharfuddin, Asif A., Adebiyi, Oluwafisayo O., Jan, Muhammad Y.   +8 more
core   +1 more source

Kidney transplantation in sub-Sahara African countries: challenges and lessons from the experience of Cameroon: a preliminary report of the first 17 pioneer cases. [PDF]

Ren Fail
Djientcheu VP, Ashuntantang G, Nono A, Kamga J, Mba S, Ngongang MP, Tebere H, Ngoundjou A, Aghogue T, Essissima F, Tiam M, Fokou M.   +11 more
europepmc   +1 more source

Early Donor-Derived Cell-Free DNA Kinetics After Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Preliminary Observational Study. [PDF]

Int J Mol Sci
Wawrzonkowski P, Gajek K, Smulska W, Grabka K, Bukowiec KM, Kuriata-Kordek M, Jerzak P, Domagalski A, Ussowicz M, Banasik M.   +9 more
europepmc   +1 more source

Economic Implications of the Use of Basiliximab in Addition to Triple Immunosuppressive Therapy in Renal Allograft Recipients: A UK Perspective

Objective: To compare resource use and costs in renal transplant recipients treated with basiliximab or placebo plus triple immunosuppressive therapy.
James B. Chilcott, Stephen J. Walters, Ronald L. Akehurst, Malcolm Whitfield   +3 more
core